KR

Karl Rudolphi

Hoechst Gmbh: 6 patents #638 of 4,020Top 20%
SA Sanofi-Aventis: 3 patents #365 of 1,008Top 40%
📍 Neu-Isenburg, DE: #7 of 146 inventorsTop 5%
Overall (All Time): #577,088 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
8809358 Use of IκB-kinase inhibitors in pain therapy Martin Michaelis, Olaf Ritzeler, Gerhard Jaehne, Gerd Geisslinger, Hans-Georg Schaible 2014-08-19
8518998 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid N-phenylamides in the treatment of pain Martin Michaelis, Hans Guehring 2013-08-27
7462638 Use of IκB-kinase inhibitors in pain therapy Martin Michaelis, Olaf Ritzeler, Gerhard Jaehne, Gerd Geisslinger, Hans-Georg Schaible 2008-12-09
6214992 Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation Ulrich Gebert, Erhard Wolf, Elisabeth Defossa, Uwe Heinelt, Hiristo Anagnostopulos +1 more 2001-04-10
6037347 Combination preparation for use in dementia Hans-Peter Schubert, Hildegard Nimmesgern 2000-03-14
5965555 Xanthine compounds having terminally animated alkynol side chains Ulrich Gebert, Elisabeth Defossa, Uwe Heinelt, John J. Grome 1999-10-12
5478831 R-(-)1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound Harald Furrer, Ulrich Gebert 1995-12-26
5409935 Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas Hans-Peter Schubert, John J. Grome, Barbara Kittner, Ulrich Gebert 1995-04-25
5407815 R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound Harald Furrer, Ulrich Gebert 1995-04-18